Background: Sickle cell anemia (SCA) is a genetic blood disorder caused by a mutation in the hemoglobin gene, leading to abnormal hemoglobin (HbS) that distorts red blood cells into a sickle shape. This impairs cell flexibility and leads to vaso-occlusion, causing a range of acute and chronic complications. SCA predominantly affects populations in Africa, the Middle East, and India. Management of this condition requires a multidisciplinary approach, with nurses playing a crucial role in symptom management, pain control, and prevention of complications.
Aim:
This review aims to provide updated insights into nursing interventions for managing sickle cell anemia, emphasizing the role of nursing professionals in enhancing patient outcomes through comprehensive care strategies.
Methods: This review synthesizes recent research on the pathophysiology, clinical manifestations, risk factors, and medical management of sickle cell anemia. It explores the nursing diagnosis, including common symptoms such as severe pain, fatigue, and infection risk, and highlights interventions for managing vaso-occlusive crises, pain, hydration, and psychosocial stressors. The management approaches discussed integrate both pharmacological and non-pharmacological strategies.
Results: The findings indicate that nurses play a pivotal role in monitoring vital signs, managing pain, providing hydration, and administering antibiotics to prevent infections. Key nursing interventions include assessing pain levels, ensuring hydration, and monitoring complications like acute chest syndrome, stroke, and infections. Nurses also engage in promoting patient education and supporting psychosocial well-being, which are crucial in improving long-term outcomes.
Conclusion: Effective nursing interventions are integral to the holistic care of patients with sickle cell anemia. A collaborative approach, focusing on symptom management and preventive care, significantly improves patient quality of life. Comprehensive nursing care can prevent complications, reduce hospitalizations, and enhance overall patient outcomes in individuals with sickle cell anemia